Blood Pressure Goals in Acute Stroke—How Low Do You Go?

Hypertension and Emergency Medicine (T Rainer and P Levy, Section Editors)
  • 28 Downloads
Part of the following topical collections:
  1. Topical Collection on Hypertension and Emergency Medicine

Abstract

Purpose of Review

Elevations in systolic blood pressure (BP) greater than 140 mmHg are reported in the majority (75%) of patients with acute ischemic stroke and in 80% of patients with acute intracerebral hemorrhages (ICH). This paper summarizes and updates the current knowledge regarding the proper management strategy for elevated BP in patients with acute stroke.

Recent Findings and Summary

Recent studies have generally showed a neutral effect of BP reduction on clinical outcomes among acute ischemic stroke patients. Thus, because of the lack of convincing evidence from clinical trials, aggressive BP reduction in patients presenting with acute ischemic stroke is currently not recommended. Although in patients treated with intravenous tissue plasminogen activator, guidelines are recommending BP < 180/105 mmHg but currently, the optimal BP management after reperfusion therapy still remains unclear. In acute ICH, the evidence from randomized clinical trials supports the immediate BP lowering targeting systolic BP to 140 mmHg, which is now recommended by guidelines.

Keywords

Blood pressure Ischemic stroke Intracerebral hemorrhage 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    •• Alsibai A, Qureshi AI. Management of Acute Hypertensive Response in Patients With Ischemic Stroke. The Neurohospitalist. 2016;6(3):122–9. This review summarizes the current data on acute hypertensive response or elevated BP management during the first 72 hours after an acute ischemic stroke. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM, et al. Prevalence of elevated blood pressure in 563 704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25(1):32–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176–87.CrossRefPubMedGoogle Scholar
  4. 4.
    Oster A, Bindman AB. Emergency department visits for ambulatory care sensitive conditions: insights into preventable hospitalizations. Med Care. 2003;41(2):198–207.PubMedGoogle Scholar
  5. 5.
    Selim AJ, Berlowitz DR, Fincke G, Rosen AK, Ren XS, Christiansen CL, et al. Risk-adjusted mortality rates as a potential outcome indicator for outpatient quality assessments. Med Care. 2002;40(3):237–45.CrossRefPubMedGoogle Scholar
  6. 6.
    Qureshi AI, Suri MF, Nasar A, et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke. 2007;38(7):2180–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Mullen MT, McKinney JS, Kasner SE. Blood pressure management in acute stroke. J Hum Hypertens. 2009;23:559–69.CrossRefPubMedGoogle Scholar
  8. 8.
    Sandset EC, Bath PM, Boysen G, et al. SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377:741–50.CrossRefPubMedGoogle Scholar
  9. 9.
    Oh MS, Yu KH, Hong KS, Kang DW, Park JM, Bae HJ, et al. Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial. Int J Stroke. 2015;10:745–51.CrossRefPubMedGoogle Scholar
  10. 10.
    He J, Zhang Y, Xu T, et al. CATIS Investigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomised clinical trial. JAMA. 2014;311:479–89.CrossRefPubMedGoogle Scholar
  11. 11.
    Bu X. Early blood pressure reduction in acute ischemic stroke with various severities: a subgroup analysis of the CATIS trial. Cerebrovasc Dis. 2016;42:186–95.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu S, Li C, Li T, Xiong J, Zhao X. Effects of early hypertension control after ischaemic stroke on the outcome: a meta-analysis. Cerebrovasc Dis. 2015;40:270–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Trial Investigators ENOS, Bath PM, Woodhouse L, Scutt P, Krishnan K, Wardlaw JM, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomized controlled trial. Lancet. 2015;385:617–28.CrossRefGoogle Scholar
  14. 14.
    COAAACS trial Robinson T, Bulpitt CJ, Ford GA, et al. Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): main results: 6A. 06. J Hypertens. 2010;28:e234.CrossRefGoogle Scholar
  15. 15.
    Wang H, Tang Y, Rong X, Li H, Pan R, Wang Y, et al. Effects of early blood pressure lowering on early and long-term outcomes after acute stroke: an updated meta-analysis. PLoS One. 2014;9:e97917.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zhao R. Blood pressure reduction in the acute phase of an ischemic stroke does not improve short- or long-term dependency or mortality. A Meta-Analysis of Current Literature. 2015;94(23):1–15.Google Scholar
  17. 17.
    Lee M, Ovbiagele B, Hong KS, Wu YL, Lee JE, Rao NM, et al. Effect of blood pressure lowering in early ischemic stroke: meta-analysis. Stroke. 2015;46:1883–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Jauch EC, Saver JL, Adams HP Jr, et al. American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.CrossRefPubMedGoogle Scholar
  19. 19.
    Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke. 2009;40:2442–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Berge E. Effects of blood pressure and blood pressure–lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke. Stroke. 2015;46:3362–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Regenhardt RW, et al. Blood pressure and penumbral sustenance in stroke from large vessel occlusion. Front Neurol. 2017;8(317)Google Scholar
  22. 22.
    Darger B, Gonzales N, Banuelos R, Peng H, Radecki R, Doshi P. Outcomes of patients requiring blood pressure control before thrombolysis with tPA for acute ischemic stroke. West J Emerg Med. 2015;16(7):1002–6.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Skolarus LE, Scott PA, Burke JF, et al. Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT Trial. Stroke. 2012;43:2–3394.CrossRefGoogle Scholar
  24. 24.
    Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27(10):1783–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. How should we lower blood pressure after cerebral hemorrhage? A systematic review and meta-analysis. Cerebrovasc Dis. 2017;43:207–13.CrossRefPubMedGoogle Scholar
  27. 27.
    Rodriguez-Luna D, Piñeiro S, Rubiera M, Ribo M, Coscojuela P, Pagola J, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20(9):1277–83.CrossRefPubMedGoogle Scholar
  28. 28.
    Sakamoto Y, Koga M, Yamagami H, et al. SAMURAI Study Investigators Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke. 2013;44(7):1846–51.CrossRefPubMedGoogle Scholar
  29. 29.
    Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis. 2013;35:195–201.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Qureshi AI. Acute blood pressure management—the North American perspective. Update on cerebral hemorrhage trials session. Presented at the International Stroke Conference; New Orleans; February 20, 2008. Available at: www.scienceondemand.org/stroke2008/sessions/player. html?sid_08020172.758. Accessed July 4, 2008.Google Scholar
  31. 31.
    Qureshi AI, The ATACH Investigators. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Trial. International Stroke Conference. New Orleans, LA, February 2008.Google Scholar
  32. 32.
    Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Manios E, et al. Blood pressure targets in acute intracerebral hemorrhage. Scientific newsletter. 2017;e64:18.Google Scholar
  34. 34.
    Butcher KS, Jeerakathil T, Hill M, Demchuk AM, Dowlatshahi D, Coutts SB, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44(3):620–6.CrossRefPubMedGoogle Scholar
  35. 35.
    McCourt R, Gould B, Gioia L, Kate M, Coutts SB, Dowlatshahi D, et al. Cerebral perfusion and blood pressure do not affect perihematoma edema growth in acute intracerebral hemorrhage. Stroke. 2014;45:1292–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Carcel C, et al. Degree and timing of intensive blood pressure lowering on hematoma growth in intracerebral hemorrhage intensive blood pressure reduction in acute cerebral hemorrhage trial-2 results. Stroke. 2016;47:1651–3.CrossRefPubMedGoogle Scholar
  37. 37.
    Schlunk F, Greenberg SM. The pathophysiology of intracerebral hemorrhage formation and expansion. Transl Stroke Res. 2015;6:257–63.CrossRefPubMedGoogle Scholar
  38. 38.
    Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.CrossRefPubMedGoogle Scholar
  39. 39.
    Morgenstern LB, Hemphill IIIJC, Anderson CS, Becker K, Broderick J, Sander Connolly E, et al. American Heart Association/American Stroke Association guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2010;41:1877–83.CrossRefGoogle Scholar
  40. 40.
    Anderson CS, Qureshi AI. Implications of INTERACT2 and other clinical trials blood pressure Management in Acute Intracerebral Hemorrhage. Stroke. 2015;46:291–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Bath PMW, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43:1171–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Howard G, Waller JL, Voeks JH, Howard VJ, Jauch EC, Lees KR, et al. A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke. 2012;43:664–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Manning L, Hirakawa Y, Arima H, Wang X, Chalmers J, Wang J, et al. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2: a randomised controlled trial. Lancet Neurol. 2014;13:364–73.CrossRefPubMedGoogle Scholar
  44. 44.
    •• Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–43. The study provides the results of ATACH2 trial. CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Gioia et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial II (ICH ADAPT II) protocol. BMC Neurology. 2017 (17):100.Google Scholar
  46. 46.
    Koch S, Romano JG, Forteza AM, Otero CM, Rabinstein AA. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care. 2008;8:316–21.CrossRefPubMedGoogle Scholar
  47. 47.
    oulouis G, Morotti A, Goldstein JN, Charidimou A. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiatry. 2017;88:339–45.CrossRefGoogle Scholar
  48. 48.
    •• Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015; 46(7):2032–2060. J. Hypertens. 34 (Suppl 1- ISH 2016 Abstract Book). 2016: e396–e397. Description of the current guidelines for the management of spontaneous intracerebral hemorrhage. Google Scholar
  49. 49.
    Pan C, Hu Y, Liu N, Zhang P, Zhang YP, Aimaiti M, et al. Aggressive blood pressure lowing therapy in patients with acute intracerebral hemorrhage is safe: a systematic review and meta-analysis. Chin Med J. 2015;128:2524–9.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8:48–56.CrossRefPubMedGoogle Scholar
  51. 51.
    Gong S, Lin C, Zhang D, Kong X, Chen J, Wang C, et al. Effects of intensive blood pressure reduction on acute intracerebral hemorrhage: a systematic review and meta-analysis. Sci Rep. 2017;7:10694.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Ma J, Li H, Liu Y, You C, Huang S, Ma L. Effects of intensive blood pressure lowering on intracerebral hemorrhage outcomes: a metaanalysis of randomized controlled trials. Turk Neurosurg. 2015;25:544–51.PubMedGoogle Scholar
  53. 53.
    Alqadri SL, Sreenivasan V, Qureshi AI. Acute hypertensive response management in patients with acute stroke. Curr Cardiol Rep. 2013;15:426.CrossRefPubMedGoogle Scholar
  54. 54.
    Arima H, Anderson CS, Wang JG, Huang Y, Heeley E, Neal B, et al. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension. 2010;56(5):852–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38(6):2001–23.CrossRefPubMedGoogle Scholar
  56. 56.
    Steiner T, AI-Shahi Salman R, Beer R, et al. European Stroke Organization (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840–55.CrossRefPubMedGoogle Scholar
  57. 57.
    Hong K-S. Blood pressure management for stroke prevention and in acute stroke. Journal of Stroke. 2017;19(2):152–65.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Zeenat Qureshi Stroke InstituteSt. CloudUSA

Personalised recommendations